Literature DB >> 23266426

CD146, a multi-functional molecule beyond adhesion.

Zhaoqing Wang1, Xiyun Yan.   

Abstract

CD146 is a cell adhesion molecule (CAM) that is primarily expressed at the intercellular junction of endothelial cells. CD146 was originally identified as a tumor marker for melanoma (MCAM) due to its existence only in melanoma but not in the corresponding normal counterpart. However CD146 is not just a CAM for the inter-cellular and cell-matrix adhesion. Recent evidence indicates that CD146 is actively involved in miscellaneous processes, such as development, signaling transduction, cell migration, mesenchymal stem cells differentiation, angiogenesis and immune response. CD146 has increasingly become an important molecule, especially identified as a novel bio-marker for angiogenesis and for cancer. Here we have reviewed the dynamic research of CD146, particularly newly identified functions and the underlying mechanisms of CD146.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266426     DOI: 10.1016/j.canlet.2012.11.049

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  104 in total

1.  The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.

Authors:  J Wang; X Tang; W Weng; Y Qiao; J Lin; W Liu; R Liu; L Ma; W Yu; Y Yu; Q Pan; F Sun
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

2.  ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model.

Authors:  Carolina A Ferreira; Reinier Hernandez; Yunan Yang; Hector F Valdovinos; Jonathan W Engle; Weibo Cai
Journal:  Mol Pharm       Date:  2018-06-25       Impact factor: 4.939

Review 3.  Murine xenogeneic models of myelodysplastic syndrome: an essential role for stroma cells.

Authors:  Xiang Li; H Joachim Deeg
Journal:  Exp Hematol       Date:  2013-10-11       Impact factor: 3.084

4.  CD146 expression in oral lichen planus and oral cancer.

Authors:  Sarinthon Pariyawathee; Ekarat Phattarataratip; Kobkan Thongprasom
Journal:  Clin Oral Investig       Date:  2019-05-17       Impact factor: 3.573

5.  Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential.

Authors:  Erika M Yazawa; Jenna E Geddes-Sweeney; Filiberto Cedeno-Laurent; Kempland C Walley; Steven R Barthel; Matthew J Opperman; Jennifer Liang; Jennifer Y Lin; Tobias Schatton; Alvaro C Laga; Martin C Mihm; Abrar A Qureshi; Hans R Widlund; George F Murphy; Charles J Dimitroff
Journal:  J Invest Dermatol       Date:  2015-03-10       Impact factor: 8.551

6.  CD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development.

Authors:  Jianan Chen; Yongting Luo; Hui Hui; Tanxi Cai; Hongxin Huang; Fuquan Yang; Jing Feng; Jingjing Zhang; Xiyun Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

7.  Serum response factor: positive and negative regulation of an epithelial gene expression network in the destrin mutant cornea.

Authors:  Sharolyn V Kawakami-Schulz; Angela M Verdoni; Shannon G Sattler; Erik Jessen; Winston W-Y Kao; Akihiro Ikeda; Sakae Ikeda
Journal:  Physiol Genomics       Date:  2014-02-18       Impact factor: 3.107

8.  Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.

Authors:  Qi Bai; Li Liu; Qilai Long; Yu Xia; Jiajun Wang; Jiejie Xu; Jianming Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.

Authors:  Haiyan Sun; Christopher G England; Reinier Hernandez; Stephen A Graves; Rebecca L Majewski; Anyanee Kamkaew; Dawei Jiang; Todd E Barnhart; Yunan Yang; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-25       Impact factor: 9.236

Review 10.  New radiotracers for imaging of vascular targets in angiogenesis-related diseases.

Authors:  Hao Hong; Feng Chen; Yin Zhang; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2014-07-30       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.